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Introduction: Differentiated thyroid cancer (DTC) is the most common endocrine cancer, accounting for 90% of the thyroid 
gland malignancies. DTC prevalence has risen in the last decades and, although the good prognosis expected for this tumor, 
recurrence in cervical lymph nodes (LN) occurs in up to 15% of patients after initial therapy. The diagnosis of cervical LN 
metastases of DTC is often complex and measurement of thyroglobulin in the washout of fine needle aspiration (FNA-Tg) 
has been used as an additional tool to detect LN disease. Nevertheless, the best cutoffs and influence of potential confounders 
are still a matter of debate. Objective: To evaluate the accuracy of FNA-Tg measurement to detect DTC metastases, seeking 
to assess the best cutoff point for the method, as well as to evaluate potential confounders, such as level of serum thyrotropin 
(TSH) and antithyroglobulin antibodies (TgAb). Methods: One hundred and thirty-eight patients with DTC and suspicious 
cervical LN were included. Patients underwent ultrasound (US) FNA guided aspiration, for both cytological examination and 
FNA-Tg measurements. Final diagnoses were determine by histological examination or by clinical and US follow-up for at least 
1 year. Results: Between October 2012 and September 2015, 138 consecutive patients with DTC and suspicious cervical LN, 
detected by palpation or cervical US, attending the Endocrine Division at our Institution were invited to participate in the stu-
dy. Data from 119 subjects (74.8% female; 45.9 years) were available for analysis. The median value of FNA-Tg in patients with 
metastatic LN (n = 65) was 3263.0 ng/mL (838.55-12507.5), while patients without LN metastasis (n = 54) showed levels of 
0.2 ng/mL (0.2-0.2). According to the ROC curve analysis, the best FNA-Tg cutoff value to predict metastasis was 4.41 ng/
mL, with sensitivity of 98% and specificity 96%. There were no differences in the median of FNA-Tg measurements between 
those on (TSH 0.16 mUI/mL) or off levothyroxine (TSH 99.41 mUI/mL) therapy (47.94 vs. 581.15 ng/mL, respectively; P 
= 0.79). Of note, the values of FNA-Tg in patients with LN metastasis (n = 65) did not differ between patients with positive or 
negative TgAb (88.8 ng/mL vs. 3263.0 ng/mL, respectively; P=0.57). Conclusion: Taken together our results demonstrated 
that measurement of FNA-Tg is an excellent tool for evaluation of suspicious LN in patients with DTC, independently of TSH 
status and presence of TgAb.
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